NASDAQ:APVO | Operating Income | Aptevo Therapeutics Inc.

Complete source-backed operating income history.

Available history
2015-09-30 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$6.44M
2026-03-31-$6.84M
2025-12-31-$6M
2025-09-30-$7.61M
2025-06-30-$6.23M
2025-03-31-$6.48M
2024-12-31-$6.38M
2024-09-30-$5.21M
2024-06-30-$6.02M
2024-03-31-$6.98M
2023-12-31-$6.38M
2023-09-30-$6.56M
2023-06-30-$8.18M
2023-03-31-$7.76M
2022-12-31-$7.68M
2022-09-30-$7.78M
2022-06-30-$7.56M
2022-03-31-$5.61M
2021-12-31-$4.04M
2021-09-30-$4.75M
2021-06-30-$5.72M
2021-03-31-$6.89M
2020-12-31-$6.82M
2020-09-30-$6.25M
2020-06-30-$6.81M
2020-03-31-$7.62M
2019-12-31-$7.94M
2019-09-30-$11.46M
2019-06-30-$12.9M
2019-03-31-$11.44M
2018-12-31-$13.59M
2018-09-30-$12.13M
2018-06-30-$12.44M
2018-03-31-$13.5M
2017-12-31-$16.82M
2017-09-30-$10.35M
2017-06-30-$14.65M
2017-03-31-$12.13M
2016-12-31-$16.87M
2016-09-30-$90.53M
2016-06-30-$12.85M
2016-03-31-$12.98M
2015-12-31-$18.5M
2015-09-30-$13.19M

Annual Operating Income

DateOperating Income
2025-12-31-$26.31M
2024-12-31-$24.6M
2023-12-31-$28.88M
2022-12-31-$28.64M
2021-12-31-$21.4M
2020-12-31-$27.49M
2019-12-31-$40.96M
2018-12-31-$51.67M
2017-12-31-$53.95M
2016-12-31-$138.77M
2015-12-31-$61.1M